Religion & Law

Wrinkle-Fillers
FDA to Review Labeling due to Adverse Event Reports

Transdermal Drug Patches
Risk of Burns Missing From Some Labeling

Dobutamine Hydrochloride Injection
Labeling Errors Prompts Recall of 250 mg/20 ml Injections

FDA
Requests Labeling Change for Singulair, Accolate and Zyflo and Zyflo CR

Food/Supplements
involving food poisoning, food product recalls, false advertising or labeling, vitamin, weight loss and diet supplement issues.